抑制劑溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 產(chǎn)品編號 | 圖片 | 產(chǎn)品描述 | 分子式 | 加入購物車 | |
|---|---|---|---|---|---|
|
H-Tyr-Gly-Gly-Phe-Met-OH，99% | C27H35N5O7S | |||
|
|
|||||
|
Tyr-Gly-Gly-Phe-Leu，99% | C28H37N5O7 | |||
|
|
|||||
|
Oxytocin Acetate，99% | C45H70N12O14S2 | |||
|
|
|||||
|
BMS-564929，98% | C14H12ClN3O3 | |||
|
|
|||||
|
TYR-D-ALA-GLY-PHE-LEU，99% | C29H39N5O7 | |||
|
|
|||||
|
trans-Tranilast，98% | C18H17NO5 | |||
|
|
|||||
|
DynorphinA(1-13)，98% | ||||
|
|
|||||
|
Naltrexone methylbromide，98% | C21H26BrNO4 | |||
|
|
|||||
|
AR231453，99% | C21H24FN7O5S | |||
|
|
|||||
|
Nestoron，99% | C23H30O4 | |||
|
|
|||||
|
TPI-1，98% | C12H6Cl2O2 | |||
|
|
|||||
|
PHTPP，98% | C20H11F6N3O | |||
|
|
|||||
|
TOLRESTAT，98% | C16H14F3NO3S | |||
|
|
|||||
|
|
6-OAU，98% | C12H21N3O2 | |||
|
|
|||||
|
Cebranopadol，98% | C24H27FN2O | |||
|
|
|||||
|
Fevipiprant，98% | C19H17F3N2O4S | |||
|
|
|||||
